
A new risk stratification model developed by Northwestern Medicine scientists may help better identify patients who have a lower risk of kidney transplant rejection, which can inform more personalized treatment and care strategies that present fewer adverse side effects, as detailed in a recent study published in Nature Communications.

In a study published in Science Advances, Northwestern Medicine scientists uncovered a previously hidden immune environment in the thymus that may help drive myasthenia gravis, a chronic autoimmune disease that causes muscle weakness and fatigue.

A landmark study from the Northwestern Medicine Canning Thoracic Institute, published in JAMA, suggests lung transplantation can significantly extend survival in select patients with advanced lung cancer.

Scientists have discovered novel molecular mechanisms that contribute to recovery from diabetic kidney following bariatric surgery in adolescents with type 2 diabetes and obesity, mechanisms that may serve as potential targets for non-surgical treatments for diabetic kidney disease, according to a multi-institutional study published in The Journal of Clinical Investigation.

Northwestern University scientists have developed the first device that can continuously track a fetus’s vital signs while still in the uterus — a feat that previously has not been possible.

In a new study of nearly 1,000 consecutive patients treated for lung cancer at Northwestern Medicine, investigators discovered only 35 percent would have qualified for screening according to the U.S. Preventive Services Task Force (USPSTF) screening criteria.

Patients with severe aortic stenosis who had a transcatheter aortic valve replacement procedure demonstrated similar seven-year survival outcomes compared to patients who had traditional surgery, according to a recent study published in The New England Journal of Medicine.

A new Northwestern Medicine study has found that, following transplant and in chronic disease states, abnormal cells emerge and “conversations” between them drive the development of transplant rejection.

A novel monoclonal antibody treatment developed in collaboration with Northwestern Medicine scientists reduced inflammation and immune dysregulation in mouse models of sepsis, underscoring the antibody’s therapeutic potential in treating the disease, according to a recent study.

A new Northwestern Medicine study is challenging long-held assumptions about chronic obstructive pulmonary disease (COPD), according to results published in The Journal of Clinical Investigation.